Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

71.4%

5 terminated/withdrawn out of 7 trials

Success Rate

16.7%

-69.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

3(42.9%)

7Total

N/A(4)

Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02552901Phase 3Withdrawn

Cardiox Liver Function Test Pivotal Trial

Role: lead

NCT02516319Not ApplicableTerminated

Liver Function Assessment - Feasibility and Dosing Study

Role: lead

NCT01773252Phase 3Terminated

Right to Left Cardiac Shunt Detection

Role: lead

NCT02257320Not ApplicableCompleted

TMJ NextGeneration(TM) Feasibility Study

Role: collaborator

NCT02446288Not ApplicableUnknown

TMJ NextGen Pilot Study to Treat Subjects With Bruxism

Role: lead

NCT02269553Not ApplicableWithdrawn

TMJ-1001 Bruxism Run-In/Pivotal Trial

Role: collaborator

NCT01333761Phase 3Terminated

Cardiox Shunt Detection Technology Study

Role: lead

All 7 trials loaded